omeprazole has been researched along with Rheumatic Diseases in 7 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Rheumatic Diseases: Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pantoprazole was superior to misoprostol (p < 0." | 2.71 | Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients. ( Dietrich, K; Fischer, R; González-Carro, P; Lühmann, R; Straszak, A; Stupnicki, T; Terjung, A; Thomas, KB, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imaeda, H | 1 |
| Ishii, H | 1 |
| Goto, M | 1 |
| Karateev, AE | 1 |
| Murav'ev, IuV | 1 |
| Radenska-Lopovok, SG | 1 |
| Nasonova, VA | 1 |
| Stupnicki, T | 1 |
| Dietrich, K | 1 |
| González-Carro, P | 1 |
| Straszak, A | 1 |
| Terjung, A | 2 |
| Thomas, KB | 2 |
| Lühmann, R | 2 |
| Fischer, R | 2 |
| Schaeverbeke, T | 1 |
| Broutet, N | 1 |
| Zerbib, F | 1 |
| Combe, B | 1 |
| Bertin, P | 1 |
| Lamouliatte, H | 1 |
| Perié, F | 1 |
| Joubert-Collin, M | 1 |
| Mégraud, F | 1 |
| Ji, KY | 1 |
| Hu, FL | 1 |
| Regula, J | 1 |
| Butruk, E | 1 |
| Dekkers, CP | 1 |
| de Boer, SY | 1 |
| Raps, D | 1 |
| Simon, L | 1 |
| Bianchi Porro, G | 1 |
| Lazzaroni, M | 1 |
| Petrillo, M | 1 |
| Manzionna, G | 1 |
| Montrone, F | 1 |
| Caruso, I | 1 |
2 reviews available for omeprazole and Rheumatic Diseases
| Article | Year |
|---|---|
[Treatment of peptic ulcer related to rheumatic diseases].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Histamine H2 Antagonists; Humans; Lu | 2002 |
Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cardiova | 2006 |
5 trials available for omeprazole and Rheumatic Diseases
| Article | Year |
|---|---|
[Efficacy of antihelicobacter therapy in NSAID-induced gastropathies].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Female; Helicobacter Infections; Humans; | 2003 |
Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti- | 2003 |
Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial | 2005 |
Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti- | 2006 |
Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Diclofenac; Double-Blind Method; Endosco | 1998 |